Back to Search
Start Over
Wilderness Medical Society consensus guidelines for the prevention and treatment of acute altitude illness.
- Source :
-
Wilderness & environmental medicine [Wilderness Environ Med] 2010 Jun; Vol. 21 (2), pp. 146-55. Date of Electronic Publication: 2010 Mar 10. - Publication Year :
- 2010
-
Abstract
- To provide guidance to clinicians about best practices, the Wilderness Medical Society (WMS) convened an expert panel to develop evidence-based guidelines for the prevention and treatment of acute mountain sickness (AMS), high altitude cerebral edema (HACE), and high altitude pulmonary edema (HAPE). These guidelines present the main prophylactic and therapeutic modalities for each disorder and provide recommendations for their roles in disease management. Recommendations are graded based on the quality of supporting evidence and balance between the benefits and risks/burdens according to criteria put forth by the American College of Chest Physicians. The guidelines also provide suggested approaches to the prevention and management of each disorder that incorporate these recommendations.<br /> (Copyright (c) 2010. Published by Elsevier Inc.)
- Subjects :
- Acetazolamide therapeutic use
Acute Disease
Albuterol analogs & derivatives
Albuterol therapeutic use
Brain Edema prevention & control
Brain Edema therapy
Carbolines therapeutic use
Dexamethasone therapeutic use
Humans
Nifedipine therapeutic use
Piperazines therapeutic use
Pulmonary Edema prevention & control
Pulmonary Edema therapy
Purines therapeutic use
Salmeterol Xinafoate
Sildenafil Citrate
Societies
Sulfones therapeutic use
Tadalafil
Altitude Sickness prevention & control
Altitude Sickness therapy
Mountaineering
Wilderness Medicine standards
Subjects
Details
- Language :
- English
- ISSN :
- 1545-1534
- Volume :
- 21
- Issue :
- 2
- Database :
- MEDLINE
- Journal :
- Wilderness & environmental medicine
- Publication Type :
- Academic Journal
- Accession number :
- 20591379
- Full Text :
- https://doi.org/10.1016/j.wem.2010.03.002